Search
Close this search box.

Category: Press Releases

EB5 Capital Celebrates the Closing of Atlanta Woodrow Apartments (JF41)

WASHINGTON, Sept. 23, 2025 (GLOBE NEWSWIRE) — EB5 Capital is pleased to announce the closing of its $42.4 million investment in Woodfield Development’s Atlanta Woodrow Apartments (JF41) project. Located in Atlanta, Georgia, the high-unemployment Target Employment Area (TEA) project is a Class A multifamily development featuring 300 units across four modern apartment buildings and 25 townhomes. The development will include expansive amenity space, including a resort-style pool and lounge, state-of-the-art fitness center, and vibrant gaming courtyard, all complemented by top-of-market interiors and finishes. Considered the financial and commercial capital of the Southeast, Atlanta is home to many major companies, including

Fitell Corporation Launches Solana (SOL) Digital Asset Treasury with $100M Financing Facility, with Focus on Yield and On-Chain DeFi Innovation

– Intends to become the largest publicly listed holder of SOL based in Australia – -Appoints advisors, David Swaney and Cailen Sullivan, to lead digital asset treasury strategy and yield generation through actively managed DeFi and structured product strategies- Taren Point, Australia, Sept. 23, 2025 (GLOBE NEWSWIRE) — Fitell Corporation (NASDAQ: FTEL) (“Fitell” or the “Company”), a global provider of fitness equipment and health solutions, today announced it has secured an up to $100M facility to support the launch of its Solana treasury strategy, marking the first Solana-based digital asset treasury in Australia. Key Highlights DeFi and Yield Roadmap: Designed

Mavenir Selected by Iridium to Deliver Core Network for Global Satellite Based NB-IoT and D2D Services

Strategic partnership to accelerate Iridium NTN Direct services and satellite-terrestrial NB-IoT integration RICHARDSON, Texas, Sept. 23, 2025 (GLOBE NEWSWIRE) — Mavenir, the cloud-native network infrastructure provider building the future of networks, today announced it has been selected by Iridium Communications Inc. (NASDAQ: IRDM), a leading provider of global voice and data satellite communications, to deploy the Core Network of its Non-Terrestrial Network (NTN), helping to enable – 3GPP based Direct-to-Device (D2D) services. In support of Iridium NTN DirectSM, Mavenir will deliver its fully containerized, cloud-native Converged Packet Core solution, hosted in Iridium’s Amazon Web Services (AWS) cloud environment. The deployment

Phelon & Moore announces collaboration with Pininfarina for a Limited Edition Capetown 7X at EICMA 2025

Phelon & Moore by Pininfarina Teaser 01 Portrait Capetown 7X design by PininfarinaTeaser image of the upcoming motorcycle in the Pininfarina wind-tunnel TURIN, Italy, Sept. 23, 2025 (GLOBE NEWSWIRE) — Phelon & Moore proudly announces the Limited Edition, 595 numbered Capetown 7X, crafted in collaboration with the legendary Italian design house Pininfarina. Famous for collaborations with iconic car brands like Ferrari, Alfa Romeo and Maserati, Pininfarina now partners with Phelon & Moore to present an unmissable motorcycle at EICMA 2025. Phelon & Moore by Pininfarina Teaser 01 Landscape Capetown 7X design by PininfarinaTeaser image of the upcoming motorcycle in the

Angelini Pharma Signs Exclusive Option Agreement With Sovargen To License Global Development and Commercialization Rights For Innovative Brain Health Asset

Angelini Pharma secures exclusive option to license global development and commercialization rights for SVG1051, a pre-clinical investigational novel compound with broad potential to treat brain health diseases, excluding the Republic of Korea, China, Hong Kong, Macau and Taiwan Sovargen receives upfront payment and is eligible for future milestone-dependent payments and royalties Agreement further expands Angelini Pharma’s strong portfolio and deep therapeutic expertise in brain health, following a series of strategic partnerships in the space, including in orphan and rare epilepsy ROME, Sept. 22, 2025 (GLOBE NEWSWIRE) — Angelini Pharma, part of the privately owned Angelini Industries, and Sovargen, a South-Korean

Recent Posts